搜尋結果
Walgreens Is Likely To Post A 25% Drop In Q3 Earnings
Forbes· 1 日前Walgreens (NASDAQ: WBA) is scheduled to report its fiscal Q3 2024 results on Thursday, June 27 ...
Gilead Stock Gets Boost from HIV Drug Study Results
The Wall Street Journal· 6 日前Shares of Gilead Sciences got a much-needed boost on Thursday after the< ...
Vertex Reaches Pricing Deal With NHS for Cystic Fibrosis Drugs
Bloomberg· 6 日前Vertex Pharmaceuticals Inc. has reached a pricing deal for its cystic fibrosis drugs with the . ...
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
CNBC· 2 日前Novo Nordisk on Monday said it will spend $4.1 billion to build a new manufacturing ... ...
Bloomberg Daybreak Europe: Tory Betting Scandal - Bloomberg
Bloomberg· 2 日前Overnight on Wall Street is morning in Europe.Monitor your investments 24 hours a ...
The Vital Difference Between Machine Learning And Generative AI
Forbes· 1 日前Discover the key differences between machine learning and generative AI. Learn how each ...
FDA OKs first menthol e-cigarettes, citing potential to help adult smokers
Bastillepost· 5 日前The Food and Drug Administration on Friday authorized ...
Pitch Deck Teardown: Feel Therapeutics' $3.5M seed deck
TechCrunch· 5 日前Feel Therapeutics is working to make mental health care more science-forward. The company makes wearable ...
Council Post: Emerging Trends In AI In Biotech
Forbes· 2 日前As an executive leading biotech research and a founder of a biotech, I've witnessed ... ...
Zealand Pharma Shares Jump 17% After Positive Trial Results For Ozempic Competitor
Forbes· 5 日前Zealand said Thursday a 16-week trial of petrelintide reduced body weight by up to 8.6% on< ...